|
C12ORF51 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.30639999929016E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.00210000000012E-05 |
| Normal-vs-Stage2 |
5.221900E-04 |
| Normal-vs-Stage3 |
1.75640000321664E-08 |
| Normal-vs-Stage4 |
1.4447999996392E-07 |
| Stage1-vs-Stage2 |
4.678800E-01 |
| Stage1-vs-Stage3 |
2.381300E-03 |
| Stage1-vs-Stage4 |
2.014200E-02 |
| Stage2-vs-Stage3 |
1.504970E-01 |
| Stage2-vs-Stage4 |
2.771000E-01 |
| Stage3-vs-Stage4 |
7.783400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.66450003674856E-09 |
| Normal-vs-AfricanAmerican |
4.641800E-03 |
| Normal-vs-Asian |
8.387000E-01 |
| Caucasian-vs-AfricanAmerican |
1.957990E-01 |
| Caucasian-vs-Asian |
5.748200E-02 |
| AfricanAmerican-vs-Asian |
2.332400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.62369961499121E-10 |
| Normal-vs-Female |
1.375340E-04 |
| Male-vs-Female |
3.784800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.903000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.8846999999832E-06 |
| Normal-vs-Age(61-80Yrs) |
2.4225000005984E-08 |
| Normal-vs-Age(81-100Yrs) |
2.444100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.568400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.204400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.768400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.263360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.114360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.479000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.628400E-01 |
| Normal-vs-Grade 2 |
4.29680000000321E-05 |
| Normal-vs-Grade 3 |
1.9827999997446E-07 |
| Normal-vs-Grade 4 |
2.32039998326883E-09 |
| Grade 1-vs-Grade 2 |
1.647820E-02 |
| Grade 1-vs-Grade 3 |
5.370300E-04 |
| Grade 1-vs-Grade 4 |
1.69324000000026E-05 |
| Grade 2-vs-Grade 3 |
3.918300E-02 |
| Grade 2-vs-Grade 4 |
4.243000E-04 |
| Grade 3-vs-Grade 4 |
6.368000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.67089999999881E-05 |
| Normal-vs-ccB subtype |
1.18789999947744E-07 |
| ccA subtype-vs-ccB subtype |
5.163700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.21400000005789E-07 |
| Normal-vs-N1 |
7.216300E-03 |
| N0-vs-N1 |
6.224400E-01 |
|
|
